Isabl Inc.
VerifiedIsabl integrates genomic and transcriptomic data to enhance cancer care decision-making.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$11—17m (Dealroom.co estimates May 2022.)
New York City New York (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
$2.0m | Grant | ||
| Total Funding | 000k | ||